Disorders of lipid metabolism such as elevated serum levels of total cholesterol (TC) [1], triglyceride (TG) [2], low-density lipoprotein cholesterol (LDL-C) [3], and apolipoprotein (Apo) B [4], or low levels of high-density lipoprotein cholesterol (HDL-C) and ApoAI [4-6] have been considered to be important risk factors in the pathogenesis of atherosclerosis and coronary artery disease (CAD). This evidence concerns the gene APOA1 and coronary artery disorder.